Tumor Inflammation–Associated Neurotoxicity Masquerading as Severe Immune Effector Cell–Associated Neurotoxicity Syndrome in a Patient With SCLC Treated With Tarlatamab: A Case Report
Author:
Masahiro Torasawa,Takehito Shukuya,Jie Huang,Reitaro Nagai,Nana Ayame,Yuta Arai,Daisuke Hayakawa,Takuo Hayashi,Tetsutaro Nagaoka,Kazuhisa Takahashi
Publication:
Journal of Thoracic Oncology
Date:
Available online 18 March 2026
© 2026 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.